KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

NORGES BANK's Holding History (CIK: 0001374170)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 2,051,899 Value ($000) $6,976 Avg Close — Range —
Q2 2018
Shares 2,051,899 Value ($000) $7,715 Avg Close — Range —
Q1 2018
Shares 2,051,899 Value ($000) $8,393 Avg Close — Range —
Q4 2017
Shares 2,051,899 Value ($000) $9,541 Avg Close — Range —
Q3 2017
Shares 2,051,899 Value ($000) $14,568 Avg Close — Range —
Q2 2017
Shares 2,005,796 Value ($000) $14,502 Avg Close — Range —
Q1 2017
Shares 1,701,935 Value ($000) $10,484 Avg Close — Range —
Q4 2016
Shares 1,701,935 Value ($000) $9,973 Avg Close — Range —
Q3 2016
Shares 1,701,935 Value ($000) $8,632 Avg Close — Range —
Q2 2016
Shares 1,701,935 Value ($000) $11,267 Avg Close — Range —
Q1 2016
Shares 1,701,935 Value ($000) $7,948 Avg Close — Range —
Q4 2015
Shares 1,811,935 Value ($000) $9,150 Avg Close — Range —
Q3 2015
Shares 941,935 Value ($000) $3,316 Avg Close — Range —
Q2 2015
Shares 941,935 Value ($000) $9,401 Avg Close — Range —
Q1 2015
Shares 605,520 Value ($000) $7,708 Avg Close — Range —